Health Insurance Innovations Inc (NASDAQ:HIIQ) CTO Sheldon Wang sold 5,000 shares of Health Insurance Innovations stock in a transaction on Friday, December 15th. The stock was sold at an average price of $27.40, for a total value of $137,000.00. Following the sale, the chief technology officer now owns 194,001 shares of the company’s stock, valued at $5,315,627.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Sheldon Wang also recently made the following trade(s):

  • On Wednesday, December 13th, Sheldon Wang sold 5,000 shares of Health Insurance Innovations stock. The stock was sold at an average price of $25.00, for a total value of $125,000.00.

Shares of Health Insurance Innovations Inc (NASDAQ HIIQ) opened at $26.90 on Monday. Health Insurance Innovations Inc has a fifty-two week low of $12.65 and a fifty-two week high of $37.38. The firm has a market capitalization of $444.95, a PE ratio of 18.30 and a beta of 0.65.

Health Insurance Innovations (NASDAQ:HIIQ) last posted its earnings results on Wednesday, November 1st. The financial services provider reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.11. Health Insurance Innovations had a return on equity of 21.32% and a net margin of 5.98%. The company had revenue of $63.34 million for the quarter, compared to analyst estimates of $59.30 million. During the same quarter in the previous year, the firm earned $0.33 earnings per share. The firm’s quarterly revenue was up 37.4% compared to the same quarter last year. equities analysts forecast that Health Insurance Innovations Inc will post 1.39 EPS for the current fiscal year.

Health Insurance Innovations declared that its board has initiated a stock repurchase plan on Monday, October 16th that authorizes the company to repurchase $50.00 million in outstanding shares. This repurchase authorization authorizes the financial services provider to buy shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board of directors believes its shares are undervalued.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Renaissance Technologies LLC grew its stake in Health Insurance Innovations by 68.3% in the second quarter. Renaissance Technologies LLC now owns 1,010,400 shares of the financial services provider’s stock valued at $23,744,000 after purchasing an additional 410,197 shares during the last quarter. Lyon Street Capital LLC grew its stake in Health Insurance Innovations by 49.4% in the third quarter. Lyon Street Capital LLC now owns 936,747 shares of the financial services provider’s stock valued at $13,583,000 after purchasing an additional 309,668 shares during the last quarter. Capital World Investors purchased a new position in Health Insurance Innovations in the second quarter valued at about $11,680,000. Emerald Mutual Fund Advisers Trust grew its stake in Health Insurance Innovations by 3.1% in the third quarter. Emerald Mutual Fund Advisers Trust now owns 462,963 shares of the financial services provider’s stock valued at $6,713,000 after purchasing an additional 14,008 shares during the last quarter. Finally, Vanguard Group Inc. grew its stake in Health Insurance Innovations by 92.2% in the first quarter. Vanguard Group Inc. now owns 406,293 shares of the financial services provider’s stock valued at $6,500,000 after purchasing an additional 194,907 shares during the last quarter. Institutional investors own 68.11% of the company’s stock.

HIIQ has been the subject of several recent research reports. Cantor Fitzgerald restated a “buy” rating and issued a $38.00 price objective on shares of Health Insurance Innovations in a report on Friday, September 1st. ValuEngine upgraded Health Insurance Innovations from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Canaccord Genuity restated a “buy” rating and issued a $39.00 price objective on shares of Health Insurance Innovations in a report on Friday, September 1st. BidaskClub upgraded Health Insurance Innovations from a “hold” rating to a “buy” rating in a report on Friday. Finally, Zacks Investment Research upgraded Health Insurance Innovations from a “hold” rating to a “strong-buy” rating and set a $24.00 price objective for the company in a report on Tuesday, October 17th. One equities research analyst has rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. Health Insurance Innovations has a consensus rating of “Buy” and an average price target of $30.86.

COPYRIGHT VIOLATION NOTICE: This report was published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://www.watchlistnews.com/insider-selling-health-insurance-innovations-inc-hiiq-cto-sells-137000-00-in-stock/1771183.html.

About Health Insurance Innovations

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Insider Buying and Selling by Quarter for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.